Loading startup

DealFlow OS
Market indexTerminal
Request accessSign in

DealFlow

Terminal access

IndexTop moversSignals
Browse index
D

Ditto Bio

Pre-Seed
www.dittobio.com/HealthcareCA, USA
Market index

Market data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.

Beta

DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.

Investor read

Evidence-bound summary — expand sections for movement, risks, and signals.

Memo snapshot · May 20, 2026, 6:12 PM

Beta

DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.

What they do

Ditto Bio Evolutionary therapies for autoimmune disease.

Funding

Raised $500K across 1 funding round. Latest: $500K Pre-seed (Jan 2026). Investors: Y Combinator. (High).

Quick read

  • •Ditto Bio Evolutionary therapies for autoimmune disease.
  • •Reported angle: Blog | Ditto Bio
  • •Indexed activity snapshot: 1 funding‑related row(s), 0 hiring‑related, 1 GitHub‑tagged, 2 product/news‑style — scoring reflects corpus coverage only.

Stage

Seed (YC)

Evidence summary

Verified facts

  • •Ditto Bio Evolutionary therapies for autoimmune disease.
  • •Reported angle: Blog | Ditto Bio
  • •Indexed activity snapshot: 1 funding‑related row(s), 0 hiring‑related, 1 GitHub‑tagged, 2 product/news‑style — scoring reflects corpus coverage only.

Recent movers

  • •May 6, 2026 · github_api — GitHub org: dittobio
  • •May 20, 2026 · ycombinator.com — Ditto Biosciences | Y Combinator
  • •May 11, 2026 · Blog / news — Blog | Ditto Bio

+1 more in Recent movement below

  • •May 6, 2026 · github_api — GitHub org: dittobio
  • •May 20, 2026 · ycombinator.com — Ditto Biosciences | Y Combinator
  • •May 11, 2026 · Blog / news — Blog | Ditto Bio
  • •May 20, 2026 · ycombinator.com — Launch YC: Ditto Bio
  • •Y Combinator

Funding

Raised $500K across 1 funding round. Latest: $500K Pre-seed (Jan 2026). Investors: Y Combinator. (High).

Hiring

No hiring/careers evidence indexed (Low).

GitHub

1 GitHub‑linked row(s) (Low).

Product / news

2 product/news‑styled row(s); headline risk without filings (High).

Traffic / social

No traffic/social evidence indexed (Low).

Funding & hiring signals

funding_articleMay 20, 2026Confidence: high

Ditto Biosciences | Y Combinator

Winter 2026 (W26) batch. Evolutionary intelligence for autoimmune disease using parasite biology.

Affected score: yesObserved: May 20, 2026Round: Pre-Seed
raisedpre-seed

Open roles (indexed)

No open roles indexed yet.

Failed or blocked links

  • public_page:_pressnot_found
    Last checked Mon, May 11, 04:38 AM

    HTTP 404

  • public_page:_newsnot_found
    Last checked Mon, May 11, 04:38 AM

    HTTP 404

  • public_page:_jobsnot_found
    Last checked Mon, May 11, 04:38 AM

    HTTP 404

  • public_page:_companynot_found
    Last checked Mon, May 11, 04:38 AM

    HTTP 404

  • public_page:_careersnot_found
    Last checked Mon, May 11, 04:38 AM

    HTTP 404

  • public_page:_aboutnot_found
    Last checked Mon, May 11, 04:38 AM

    HTTP 404

DealFlow growth score
50.0Moderate public activity signal
7D-36%
30D+4%
Needs Review

The score is an algorithmic estimate based on observed public company-level signals. It may be incomplete, stale, or inaccurate and is not investment, legal, tax, or business advice.

Source health

  • public_market_enrichmentok
    Last checked Mon, May 11, 04:38 AM
  • public_page:_blogok
    Last checked Mon, May 11, 04:38 AM
  • public_page:_ok
    Last checked Mon, May 11, 04:38 AM
  • public_page:homeok
    Last checked Mon, May 11, 04:38 AM
  • githubok
    Last checked Thu, May 7, 01:24 AM

DealFlow score momentum

507D -3630D +4
100500
2026-05-20: 50

More runs will build history.

The score is an algorithmic estimate based on observed public company-level signals. It may be incomplete, stale, or inaccurate and is not investment, legal, tax, or business advice.

Signal breakdown

Latest momentum signal per category. Expand a card to inspect raw payloads.

Public source summary

Total evidence rows
6
Latest evidence
Wed, May 20, 06:12 PM

Source types found

blogcompany_sitefunding_articlegithubpress

Strongest / recent news-style rows

  • Ditto Biosciences | Y Combinator

    Wed, May 20, 06:12 PM · confidence 88%high quality

    https://www.ycombinator.com/companies/ditto-biosciences
  • Launch YC: Ditto Bio

    Wed, May 20, 06:12 PM · confidence 85%medium quality

    https://www.ycombinator.com/launches/PNb-ditto-bio-evolutionary-therapies-for-autoimmune-disease

Public signal timeline

Newest first · 6 event(s)

1
Wed, May 20, 06:12 PM · company_site · 85% · verified_publichigh quality

Ditto Bio

Evolutionary therapies for autoimmune disease.

Source ↗
2
Wed, May 20, 06:12 PM · funding_article · 88% · verified_publichigh quality

Ditto Biosciences | Y Combinator

Winter 2026 (W26) batch. Evolutionary intelligence for autoimmune disease using parasite biology.

Source ↗
3
Mon, May 11, 04:38 AM · blog · 70% · publichigh quality

Blog | Ditto Bio

Source: Blog / news

Insights from Ditto Bio on drug discovery and biotechnology.

Source ↗
4
Thu, May 7, 01:24 AM · github · 92% · verified_publichigh quality

GitHub org: dittobio

Source: github_api

Source ↗
5
Wed, May 20, 06:12 PM · press · 85% · verified_publicmedium quality

Launch YC: Ditto Bio

AI platform for parasite-derived immunomodulators.

Source ↗
6
Thu, May 7, 01:24 AM · github · 65% · verified_publiclow quality

GitHub repo: dittobio/ditto-blood-drive

Source: github_api

Source ↗

Official / company site

1 row(s)

company_site·Wed, May 20, 06:12 PM·Confidence 85%high qualityverified_public

Ditto Bio

Evolutionary therapies for autoimmune disease.

https://www.dittobio.com/

News

1 row(s)

press·Wed, May 20, 06:12 PM·Confidence 85%medium qualityverified_public

Launch YC: Ditto Bio

AI platform for parasite-derived immunomodulators.

https://www.ycombinator.com/launches/PNb-ditto-bio-evolutionary-therapies-for-autoimmune-disease

Funding / news

1 row(s)

funding_article·Wed, May 20, 06:12 PM·Confidence 88%high qualityverified_public

Ditto Biosciences | Y Combinator

Winter 2026 (W26) batch. Evolutionary intelligence for autoimmune disease using parasite biology.

https://www.ycombinator.com/companies/ditto-biosciences

GitHub

2 row(s)

github·Thu, May 7, 01:24 AM·Confidence 92%high qualityverified_public

GitHub org: dittobio

Source name: github_api

https://github.com/dittobio
github·Thu, May 7, 01:24 AM·Confidence 65%low qualityverified_public

GitHub repo: dittobio/ditto-blood-drive

Source name: github_api

https://github.com/dittobio/ditto-blood-drive

Blog

1 row(s)

blog·Mon, May 11, 04:38 AM·Confidence 70%high qualitypublic

Blog | Ditto Bio

Source name: Blog / news

Insights from Ditto Bio on drug discovery and biotechnology.

https://www.dittobio.com/blog

Private workspace

Sign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.

Sign in
DealFlow OS · Public market terminal
Privacy PolicyTerms & Conditions